Key result
Soft nanomaterial bioelectronics overcome rigid device limitations for cardiac monitoring by enabling conformal tissue interfacing.
Why the study?
Conventional rigid and bulky cardiac devices pose challenges for long-term interfacing with the curvilinear, dynamically beating heart.
Answers are grounded in this paper and cite their sources.
Soft bioelectronics utilizing elastic conductive nanocomposites offer a promising next-generation approach to overcome the limitations of conventional rigid cardiac devices by conforming to the dynamically beating heart.
Cardiac interfacing devices are essential components for the management of cardiovascular diseases, particularly in terms of electrophysiological monitoring and implementation of therapies. However, conventional cardiac devices are typically composed of rigid and bulky materials and thus pose significant challenges for effective long-term interfacing with the curvilinear surface of a dynamically beating heart. In this regard, the recent development of intrinsically soft bioelectronic devices using nanocomposites, which are fabricated by blending conductive nanofillers in polymeric and elastomeric matrices, has shown great promise. The intrinsically soft bioelectronics not only endure the dynamic beating motion of the heart and maintain stable performance but also enable conformal, reliable, and large-area interfacing with the target cardiac tissue, allowing for high-quality electrophysiological mapping, feedback electrical stimulations, and even mechanical assistance. Here, we explore next-generation cardiac interfacing strategies based on soft bioelectronic devices that utilize elastic conductive nanocomposites. We first discuss the conventional cardiac devices used to manage cardiovascular diseases and explain their undesired limitations. Then, we introduce intrinsically soft polymeric materials and mechanical restraint devices utilizing soft polymeric materials. After the discussion of the fabrication and functionalization of conductive nanomaterials, the introduction of intrinsically soft bioelectronics using nanocomposites and their application to cardiac monitoring and feedback therapy follow. Finally, comments on the future prospects of soft bioelectronics for cardiac interfacing technologies are discussed.
No takes yet. Share an insight, caveat, or question.
Han et al. (2024) conducted a review in Cardiovascular diseases. Nanomaterial-based soft bioelectronics vs. Conventional rigid cardiac devices was evaluated. Nanomaterial-based soft bioelectronics enable conformal and reliable interfacing with cardiac tissue, overcoming the limitations of conventional rigid devices for electrophysiological monitoring.
Synapse has enriched 10 related papers. Consider them for comparative context: